Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker LLY
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 295,000 | $405.2M | — | Oct 30, 2026 | — | Form 144 ↗ |
| Oct 15, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 305,000 | $368.7M | — | Oct 15, 2026 | — | Form 144 ↗ |
| Oct 7, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 300,000 | $347.2M | — | Oct 7, 2026 | — | Form 144 ↗ |
| Aug 17, 2026 | Patrik Jonsson Officer | LLY Eli Lilly and Company | 6,500 | $7.6M | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 1 day later · 6,500 shares | Form 144 ↗ |
| Aug 10, 2026 | Donald Zakrowski Officer | LLY Eli Lilly and Company | 2,000 | $2.4M | 10b5-1 | Aug 10, 2026 | Form 4 ↗ 1 day later · 2,000 shares | Form 144 ↗ |
| Aug 7, 2026 | Hakim Anat Officer | LLY Eli Lilly and Company | 10,000 | $11.9M | 10b5-1 | Aug 7, 2026 | Form 4 ↗ 3 days later · 5,000 shares | Form 144 ↗ |
| Jul 7, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 310,000 | $372.0M | — | Jul 7, 2026 | — | Form 144 ↗ |
| Jun 26, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 305,000 | $343.9M | — | Jun 26, 2026 | — | Form 144 ↗ |
| Jun 10, 2026 | Yuffa Ilya Officer | LLY Eli Lilly and Company | 2,500 | $2.9M | 10b5-1 | Jun 10, 2026 | Form 4 ↗ 1 day later · 2,500 shares | Form 144 ↗ |
| May 28, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 310,000 | $335.7M | — | May 28, 2026 | — | Form 144 ↗ |
| May 22, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 300,000 | $312.5M | — | May 22, 2026 | — | Form 144 ↗ |
| May 20, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 305,000 | $311.5M | — | May 20, 2026 | — | Form 144 ↗ |
| May 6, 2026 | Lilly Endowment, Inc. Shareholder | LLY Eli Lilly and Company | 300,000 | $296.7M | — | May 6, 2026 | Form 4 ↗ 1 day later · 15,828 shares | Form 144 ↗ |
| Dec 23, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 300,000 | $322.9M | — | Dec 23, 2025 | Form 4 ↗ 6 days later · 240 shares | Form 144 ↗ |
| Nov 24, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 305,000 | $323.2M | — | Nov 24, 2025 | Form 4 ↗ 1 day later · 142,307 shares | Form 144 ↗ |
| Nov 19, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 310,000 | $319.3M | — | Nov 19, 2025 | Form 4 ↗ 1 day later · 167,526 shares | Form 144 ↗ |
| Nov 13, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 295,000 | $300.2M | — | Nov 13, 2025 | Form 4 ↗ 1 day later · 46,606 shares | Form 144 ↗ |
| Nov 12, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 305,000 | $301.5M | — | Nov 12, 2025 | Form 4 ↗ 1 day later · 305,000 shares | Form 144 ↗ |
| Nov 10, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 300,000 | $277.3M | — | Nov 10, 2025 | Form 4 ↗ 2 days later · 16,869 shares | Form 144 ↗ |
| Nov 4, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 220,000 | $197.2M | — | Nov 4, 2025 | Form 4 ↗ 1 day later · 526 shares | Form 144 ↗ |
| Nov 3, 2025 | Lilly Endowment, Inc. 10% Stockholder | LLY Eli Lilly and Company | 300,000 | $258.9M | — | Nov 3, 2025 | Form 4 ↗ 1 day later · 300,000 shares | Form 144 ↗ |
| Oct 10, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 305,000 | $260.9M | — | Oct 10, 2025 | Form 4 ↗ 4 days later · 3,658 shares | Form 144 ↗ |
| Oct 6, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 300,000 | $252.0M | — | Oct 6, 2025 | Form 4 ↗ 1 day later · 161,183 shares | Form 144 ↗ |
| Oct 2, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 305,000 | $251.8M | — | Oct 2, 2025 | Form 4 ↗ 1 day later · 112,596 shares | Form 144 ↗ |
| Oct 1, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 295,000 | $225.1M | — | Oct 1, 2025 | Form 4 ↗ 1 day later · 135,193 shares | Form 144 ↗ |
| Sep 18, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 300,000 | $228.0M | — | Sep 18, 2025 | Form 4 ↗ 1 day later · 106,626 shares | Form 144 ↗ |
| Aug 28, 2025 | Donald Zakrowski Officer | LLY Eli Lilly and Company | 2,000 | $1.5M | 10b5-1 | Aug 28, 2025 | Form 4 ↗ same day · 1,000 shares | Form 144 ↗ |
| Jul 24, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 280,000 | $223.7M | — | Jul 24, 2025 | Form 4 ↗ 1 day later · 280,000 shares | Form 144 ↗ |
| May 14, 2025 | Yuffa Ilya Officer | LLY Eli Lilly and Company | 2,500 | $1.9M | 10b5-1 | May 14, 2025 | Form 4 ↗ 1 day later · 1,250 shares | Form 144 ↗ |
| Mar 13, 2025 | Donald Zakrowski Officer | LLY Eli Lilly and Company | 2,000 | $1.6M | 10b5-1 | Mar 13, 2025 | Form 4 ↗ same day · 1,000 shares | Form 144 ↗ |
| Mar 3, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 220,000 | $202.5M | — | Mar 3, 2025 | Form 4 ↗ 1 day later · 220,000 shares | Form 144 ↗ |
| Feb 25, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 225,000 | $198.3M | — | Feb 25, 2025 | Form 4 ↗ 1 day later · 225,000 shares | Form 144 ↗ |
| Feb 13, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 220,000 | $192.1M | — | Feb 13, 2025 | Form 4 ↗ 1 day later · 35,446 shares | Form 144 ↗ |
| Feb 10, 2025 | Daniel Skovronsky Officer | LLY Eli Lilly and Company | 5,000 | $4.3M | 10b5-1 | Feb 10, 2025 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Feb 6, 2025 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 210,000 | $176.9M | — | Feb 6, 2025 | Form 4 ↗ 1 day later · 210,000 shares | Form 144 ↗ |
| Nov 8, 2024 | Donald A. Zakrowski Officer | LLY Eli Lilly and Company | 900 | $723.0K | 10b5-1 | Nov 8, 2024 | Form 4 ↗ same day · 900 shares | Form 144 ↗ |
| Aug 26, 2024 | Donald A. Zakrowski Officer | LLY Eli Lilly and Company | 750 | $712.5K | 10b5-1 | Aug 26, 2024 | Form 4 ↗ 74 days later · 900 shares | Form 144 ↗ |
| Aug 22, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 215,000 | $204.7M | — | Aug 22, 2024 | — | Form 144 ↗ |
| Jul 10, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 210,000 | $195.8M | — | Jul 10, 2024 | — | Form 144 ↗ |
| Jun 28, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 215,000 | $195.4M | — | Jun 28, 2024 | — | Form 144 ↗ |
| Jun 20, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 215,000 | $191.7M | — | Jun 20, 2024 | — | Form 144 ↗ |
| Jun 14, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 210,000 | $185.5M | — | Jun 14, 2024 | — | Form 144 ↗ |
| Jun 7, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 215,000 | $180.0M | — | Jun 7, 2024 | — | Form 144 ↗ |
| Jun 5, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 200,000 | $166.5M | — | Jun 5, 2024 | — | Form 144 ↗ |
| Jun 3, 2024 | Norton Johna Officer | LLY Eli Lilly and Company | 7,056 | $5.8M | 10b5-1 | Jun 3, 2024 | — | Form 144 ↗ |
| Jun 3, 2024 | Donald A. Zakrowski Officer | LLY Eli Lilly and Company | 750 | $614.6K | 10b5-1 | Jun 3, 2024 | — | Form 144 ↗ |
| May 31, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 215,000 | $175.2M | — | May 31, 2024 | — | Form 144 ↗ |
| May 24, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 225,000 | $181.9M | — | May 24, 2024 | — | Form 144 ↗ |
| May 21, 2024 | Lilly Endowment Inc 10% Stockholder | LLY Eli Lilly and Company | 250,000 | $195.8M | — | May 21, 2024 | — | Form 144 ↗ |
| Mar 11, 2024 | Donald A. Zakrowski Officer | LLY Eli Lilly and Company | 750 | $565.2K | 10b5-1 | Mar 11, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances